市场调查报告书
商品编码
1530720
氧化铈奈米颗粒的全球市场预测(~2030 年):按形式、应用、最终用户和地区进行分析Cerium Oxide Nanoparticles Market Forecasts to 2030 - Global Analysis By Form, Application (Chemical Mechanical Planarization, Polishing Agent, Coatings, Energy Storage, Sunscreen Cosmetics, Catalyst and Other Applications), End User and by Geography |
2024年全球氧化铈奈米粒子市场规模为9.2879亿美元,预计2030年将达到29.7323亿美元,预测期内复合年增长率为21.4%。
氧化铈奈米颗粒(简称 CeO2 奈米颗粒)具有特殊的性质,使其可用于多种应用。由于它们能够在 Ce3+ 和 Ce4+ 氧化态之间转变,这些奈米颗粒以其促进氧化还原反应的高触媒活性而闻名。它还在汽车触媒转换器中发挥重要作用,其卓越的储氧能力可减少排放。
据美国化学会称,奈米技术的进步彻底改变了材料科学,并在从医学到能源储存等领域实现了突破。
汽车触媒转换器的需求增加
奈米氧化铈具有有效的储氧和释氧能力,广泛应用于汽车触媒转换器。藉助此特性,氮氧化物和一氧化碳等有毒气体可以转化为氮气和二氧化碳等毒性较小的排放气体。此外,汽车产业专注于减少车辆排放气体以遵守严格的环境法规,这导致对氧化铈奈米颗粒的需求显着增加。
扩充性和成本问题
以商业规模生产氧化铈奈米粒子的高成本是主要障碍之一。高生产成本通常是由于合成品质和纯度一致的奈米颗粒所需的复杂程序和专用设备造成的。此外,这可能会阻碍奈米颗粒的广泛使用,特别是在预算紧张的市场和规模经济至关重要的情况下。
生物医学和医疗保健技术开发
氧化铈奈米颗粒为医疗保健产业的新型治疗方法、标靶药物传递方法和诊断设备提供了前景。氧化铈奈米颗粒的生物相容性和抗氧化特性使其特别适用于治疗与氧化压力相关的疾病、促进创伤治疗和推进诊断成像方法。此外,进一步的研究可能会改善医疗保健结果和个人化医疗。
激烈的竞争与替代品
氧化铈和其他奈米颗粒相关材料和技术是市场上的激烈竞争者,提供可比或更好的品质。材料科学和奈米技术的进步可能会带来更经济、更有效或更环保的替代方案。此外,根据市场和应用,对氧化铈奈米颗粒的需求可能会减少。
氧化铈奈米颗粒市场受到了 COVID-19 大流行的各种影响。最初,由于全球供应链和製造业务中断,生产和分销延迟影响了市场供应。汽车、电子和建筑等大量使用氧化铈奈米粒子的行业的需求因工业活动减少和许多国家实施的严格封锁而进一步受到抑制。然而,随着经济逐渐復苏,需求增加,特别是在氧化铈奈米粒子用于诊断和治疗剂的医疗保健应用。
预计粉末细分市场在预测期内将是最大的
粉末部分通常在氧化铈奈米粒子市场中占据最大份额。粉末状氧化铈奈米粒子广泛应用于各个行业,因为它们易于处理、用途广泛,并且可以纳入各种製造过程。铈奈米颗粒广泛应用于汽车触媒转换器中用于排放控制,其高表面积和催化性能非常重要。此外,粉状氧化铈奈米粒子由于其研磨性能和实现精细表面光洁度的能力,已在精密光学、电子和陶瓷的磨料中得到应用。
预计医疗保健领域在预测期内复合年增长率最高
在氧化铈奈米颗粒市场中,医疗保健领域通常表现出最高的复合年增长率。这一增长是由专注于利用氧化铈奈米颗粒进行生物医学应用的研发活动的增加所推动的。在医疗保健领域,正在评估这些奈米颗粒的抗氧化特性、生物相容性以及在治疗氧化压力相关疾病和增强药物传输系统方面的潜在治疗效果。此外,它在诊断成像和生物标记检测中的作用进一步推动了需求。
亚太地区通常在氧化铈奈米粒子市场中占据最大份额。中国、日本、韩国和印度等国家广泛的工业活动,特别是汽车和电子产业,支持了这一优势。这些国家强大的先进材料研发基础设施使得氧化铈奈米粒子在触媒转换器、电子抛光和其他工业应用中广泛使用。此外,该地区庞大的市场占有率主要归因于医疗基础设施投资的增加以及对尖端医疗技术的需求不断增长。
北美氧化铈奈米粒子市场的复合年增长率最高。研发投资的增加,特别是在环境和生物医学应用方面的投资,是这项成长的主要驱动力。促进使用氧化铈奈米粒子等尖端材料的创新和法律规范在北美受到好评。此外,该地区强劲的医疗保健产业和严格的环境法规创造了对清洁技术的需求,也推动了市场的成长。
According to Stratistics MRC, the Global Cerium Oxide Nanoparticles Market is accounted for $928.79 million in 2024 and is expected to reach $2973.23 million by 2030 growing at a CAGR of 21.4% during the forecast period. Cerium oxide nanoparticles, or CeO2 nanoparticles for short, have special qualities that make them useful for a range of applications. Because of their capacity to transition between the oxidation states of Ce3+ and Ce4+, these nanoparticles are well-known for their high catalytic activity, which promotes redox reactions. They also play a critical role in automobile catalytic converters, which reduce exhaust emissions owing to their remarkable oxygen storage capacity.
According to the American Chemical Society, advancements in nanotechnology have revolutionized materials science and enabled breakthroughs in fields ranging from medicine to energy storage.
Increasing demand for car catalytic converters
Due to their effective oxygen storage and release capabilities, cerium oxide nanoparticles are widely utilized in automotive catalytic converters. With the help of this characteristic, toxic gases like nitrogen oxides and carbon monoxide can be converted into less toxic emissions like nitrogen and carbon dioxide. Additionally, the heightened emphasis on vehicle emissions reduction by the automotive industry in order to comply with strict environmental regulations has led to a notable increase in the demand for cerium oxide nanoparticles.
Scalability and cost concerns
The high cost of producing cerium oxide nanoparticles on a commercial scale is one of the main obstacles. Higher production costs are often caused by the need for complex procedures and specialized equipment in the synthesis of nanoparticles with consistent quality and purity. Furthermore, this may prevent them from being widely used, especially in markets with tight budgets or in situations where economies of scale are essential.
Technological developments in biomedicine and healthcare
Cerium oxide nanoparticles present prospects for novel therapeutic treatments, targeted drug delivery methods, and diagnostic instruments in the healthcare industry. Their biocompatibility and antioxidant qualities are especially helpful in treating diseases linked to oxidative stress, promoting wound healing, and advancing imaging methods. Moreover, improved healthcare outcomes and personalized medicine may be possible with further research.
Severe rivalry and substitution
Cerium oxide and other nanoparticles-related materials and technologies are fierce competitors in the market, offering comparable or better qualities. Developments in materials science and nanotechnology could result in the creation of more economical, effective, or environmentally friendly alternatives. Additionally, in some markets and applications, this might lessen the need for cerium oxide nanoparticles.
The market for cerium oxide nanoparticles has experienced a variety of effects from the COVID-19 pandemic. Initially, delays in production and distribution had an impact on market availability due to disruptions in global supply chains and manufacturing operations. The demand from industries that use cerium oxide nanoparticles extensively, like the automotive, electronics, and construction sectors, was further suppressed by a reduction in industrial activity and strict lockdown measures implemented in many nations. However, demand increased as economies gradually recovered, especially in healthcare applications where cerium oxide nanoparticles are used in diagnostics and therapeutics.
The Powder segment is expected to be the largest during the forecast period
The powder segment typically holds the largest share in the cerium oxide nanoparticles market. Powdered cerium oxide nanoparticles are widely used across various industries due to their ease of handling, versatile applications, and ability to be integrated into different manufacturing processes. They are extensively employed in automotive catalytic converters for emissions control, where their high surface area and catalytic properties are crucial. Additionally, powdered cerium oxide nanoparticles find applications in polishing agents for precision optics, electronics, and ceramics due to their abrasive properties and ability to achieve fine surface finishes.
The Healthcare segment is expected to have the highest CAGR during the forecast period
The healthcare segment typically exhibits the highest CAGR in the cerium oxide nanoparticles market. This growth is driven by increasing research and development activities focused on utilizing cerium oxide nanoparticles in biomedical applications. In healthcare, these nanoparticles are valued for their antioxidant properties, biocompatibility, and potential therapeutic benefits in treating oxidative stress-related diseases and enhancing drug delivery systems. Moreover, their role in diagnostic imaging and biomarker detection further boosts demand.
In the cerium oxide nanoparticle market, the Asia-Pacific region usually holds the largest share. Widespread industrial activity in nations like China, Japan, South Korea, and India, especially in the automotive and electronics industries, is what fuels this dominance. The extensive use of cerium oxide nanoparticles in catalytic converters, electronics polishing, and other industrial applications is made possible by these countries strong infrastructures for advanced material research and development. Furthermore, the region's substantial market share is also largely due to rising investments in healthcare infrastructure and rising demand for cutting-edge medical technologies.
The North American region has the highest CAGR in the cerium oxide nanoparticles market. Growing investments in R&D, especially in environmental and biomedical applications, are the main driver of this growth. Technological innovation and regulatory frameworks that facilitate the use of cutting-edge materials such as cerium oxide nanoparticles are highly valued in North America. Moreover, propelling market growth is the region's robust healthcare sector and strict environmental regulations that are creating a demand for cleaner technologies.
Key players in the market
Some of the key players in Cerium Oxide Nanoparticles market include Solvay, Nyacol Nano Technologies Inc., BASF, Advanced Nano Products Co., Ltd., Evonik Industries, Inframat Corporation, Strem Chemicals, Inc., Meliorum Technologies, Inc., Nanoshell, American Elements Inc, SkySpring Nanomaterials, Inc., Umicore, Cerion, LLC, Nanophase Technologies Corporation and Plasmachem GmbH.
In July 2024, BASF and ENGIE have signed a seven year biomethane purchase agreement (BPA). Under the BPA, ENGIE will supply BASF with 2.7 to 3.0 terawatt hours of biomethane throughout the term of the agreement. BASF uses certified biomethane at its Ludwigshafen,Germany and Antwerp,Belgium sites as a sustainable alternative to fossil raw materials in its manufacturing process.
In June 2024, Solvay, a leader in rare earth materials supply for catalysis and electronics, and Cyclic Materials, an advanced metals recycling company building a circular supply chain for rare earth elements and other critical metals, announced the signing of an agreement for the supply of recycled mixed rare earth oxide (rMREO) from Cyclic Materials to Solvay, with shipments to begin in late 2024.
In February 2024, Vattenfall and Evonik have inked new long-term electricity supply contracts, aiming to bolster Evonik's green energy consumption for chemical production. Commencing in 2025, two solar parks operated by Vattenfall in Schleswig-Holstein will furnish Evonik with approximately 120 gigawatt hours of solar power annually over a decade, under fixed conditions termed as "Power Purchase Agreements" (PPA).